Statements (34)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
|
gptkbp:appearance |
white crystalline solid
|
gptkbp:ATCCode |
N02BA05
|
gptkbp:boilingPoint |
Not applicable (decomposes)
|
gptkbp:CASNumber |
65-45-2
|
gptkbp:category |
non-opioid analgesic
antipyretic salicylamide derivative |
gptkbp:chemicalFormula |
C7H7NO2
|
gptkbp:hasInChIKey |
InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10)
QHUFMAHRWVTWDM-UHFFFAOYSA-N |
gptkbp:hasSMILES |
C1=CC=C(C(=C1)C(=O)N)O
|
https://www.w3.org/2000/01/rdf-schema#label |
salicylamide
|
gptkbp:IUPACName |
2-hydroxybenzamide
|
gptkbp:KEGGID |
C07398
|
gptkbp:meltingPoint |
140–144 °C
|
gptkbp:molecularWeight |
137.14 g/mol
|
gptkbp:PubChem_CID |
4965
5147 CHEBI:32168 |
gptkbp:relatedTo |
gptkb:paracetamol
gptkb:salicylic_acid |
gptkbp:riskFactor |
may cause skin and eye irritation
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:solubility |
slightly soluble
|
gptkbp:structure |
contains amide group
contains benzene ring contains hydroxyl group |
gptkbp:UNII |
O414PZ4LPZ
|
gptkbp:uses |
analgesic
antipyretic component in over-the-counter medications |
gptkbp:bfsParent |
gptkb:salicylic_acid
|
gptkbp:bfsLayer |
7
|